The journal of nutrition, health & aging

, Volume 22, Issue 4, pp 508–512 | Cite as

Association between Serum Uric Acid Level and Carotid Atherosclerosis in Chinese Individuals Aged 75 Years or Older: A Hospital-Based Case-Control Study

  • Liangshu Feng
  • Cong Hua
  • H. Sun
  • L.-Y. Qin
  • P.-P. Niu
  • Zhen-Ni Guo
  • Yi Yang



To investigate the association between serum uric acid level and the presence and progression of carotid atherosclerosis in Chinese individuals aged 75 years or older.


Case-control study.


In a teaching hospital.


Five hundred and sixty-four elderlies (75 years or above) who underwent general health screening in our hospital were enrolled.


The detailed carotid ultrasound results, physical examination information, medical history, and laboratory test results including serum uric acid level were recorded, these data were used to analyze the relationship between serum uric acid level and carotid atherosclerosis. Then, subjects who underwent the second carotid ultrasound 1.5-2 years later were further identified to analyzed the relationship between serum uric acid and the progression of carotid atherosclerosis.


A total of 564 subjects were included, carotid plaque was found in 482 (85.5%) individuals. Logistic regression showed that subjects with elevated serum uric acid (expressed per 1 standard deviation change) had significantly higher incidence of carotid plaque (odds ratio, 1.37; 95% confidence interval, 1.07–1.75; P= 0.012) after controlling for other factors. A total of 236 subjects underwent the follow-up carotid ultrasound. Linear regression showed that serum uric acid level (expressed per 1 standard deviation change; 1 standard deviation = 95.5 μmol/L) was significantly associated with percentage of change of plaque score (P = 0.008). Multivariable linear regression showed that 1 standard deviation increase in serum uric acid levels was expected to increase 0.448% of plaque score (P = 0.023).


The elevated serum uric acid level may be independently and significantly associated with the presence and progression of carotid atherosclerosis in Chinese individuals aged 75 years or older.

Key words

Carotid atherosclerosis carotid plaque uric acid carotid ultrasound elder population 



diabetes mellitus


low density lipoprotein cholesterol


high density lipoprotein cholesterol


total cholesterol


body mass index


  1. 1.
    Sun R, Cao H, Zhu X, Liu JP, Dong E. Current aging research in China. Protein & cell, 2015;6:314–321.CrossRefGoogle Scholar
  2. 2.
    Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middleaged men and women in Finland. Circulation, 1999;99:1165–1172.CrossRefPubMedGoogle Scholar
  3. 3.
    Liu M, Wu B, Wang WZ, Lee LM, Zhang SH, Kong LZ. Stroke in China: epidemiology, prevention, and management strategies. The Lancet Neurology, 2007;6:456–464.CrossRefPubMedGoogle Scholar
  4. 4.
    Owolabi MO, Akpa OM, Agunloye AM. Carotid IMT is more associated with stroke than risk calculators. Acta neurologica Scandinavica, 2016;133:442–450.CrossRefPubMedGoogle Scholar
  5. 5.
    Morito N, Inoue Y, Urata M, Yahiro E, Kodama S, Fukuda N, Saito N, Tsuchiya Y, Mihara H, Yamanouchi Y, Saku K, Urata H. Increased carotid artery plaque score is an independent predictor of the presence and severity of coronary artery disease. Journal of cardiology, 2008;51:25–32.CrossRefPubMedGoogle Scholar
  6. 6.
    Bekwelem W, Jensen PN, Norby FL, Soliman EZ, Agarwal SK, Lip GY, Pan W, Folsom AR, Longstreth WT, Jr., Alonso A, Heckbert SR, Chen LY. Carotid Atherosclerosis and Stroke in Atrial Fibrillation: The Atherosclerosis Risk in Communities Study. Stroke; a journal of cerebral circulation, 2016;47:1643–1646.CrossRefPubMedCentralGoogle Scholar
  7. 7.
    Pan XF, Lai YX, Gu JQ, Wang HY, Liu AH, Shan ZY. Factors Significantly Associated With the Increased Prevalence of Carotid Atherosclerosis in a Northeast Chinese Middle-aged and Elderly Population: A Cross-sectional Study. Medicine, 2016;95:e3253.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, Wamsley A, Sheikh-Hamad D, Lan HY, Feng L, Johnson RJ. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogenactivated protein kinase and cyclooxygenase-2. Hypertension, 2003;41:1287–1293.CrossRefPubMedGoogle Scholar
  9. 9.
    Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, Krotova K, Block ER, Prabhakar S, Johnson RJ. Hyperuricemia induces endothelial dysfunction. Kidney international, 2005;67:1739–1742.CrossRefPubMedGoogle Scholar
  10. 10.
    Nakagawa T, Mazzali M, Kang DH, Kanellis J, Watanabe S, Sanchez-Lozada LG, Rodriguez-Iturbe B, Herrera-Acosta J, Johnson RJ. Hyperuricemia causes glomerular hypertrophy in the rat. American journal of nephrology, 2003;23:2–7.CrossRefPubMedGoogle Scholar
  11. 11.
    Takayama S, Kawamoto R, Kusunoki T, Abe M, Onji M. Uric acid is an independent risk factor for carotid atherosclerosis in a Japanese elderly population without metabolic syndrome. Cardiovascular diabetology, 2012;11:2.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Li Q, Zhou Y, Dong K, Wang A, Yang X, Zhang C, Zhu Y, Wu S, Zhao X. The Association between Serum Uric Acid Levels and the Prevalence of Vulnerable Atherosclerotic Carotid Plaque: A Cross-sectional Study. Scientific reports, 2015;5:10003.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Tiozzo E, Gardener H, Hudson BI, Dong C, Della-Morte D, Crisby M, Goldberg RB, Elkind MS, Cheung YK, Wright CB, Sacco RL, Desvarieux M, Rundek T. Subfractions of High-Density Lipoprotein-Cholesterol and Carotid Intima-Media Thickness: The Northern Manhattan Study. Stroke; a journal of cerebral circulation, 2016;47:1508–1513.CrossRefPubMedCentralGoogle Scholar
  14. 14.
    Handa N, Matsumoto M, Maeda H, Hougaku H, Kamada T. Ischemic stroke events and carotid atherosclerosis. Results of the Osaka Follow-up Study for Ultrasonographic Assessment of Carotid Atherosclerosis (the OSACA Study). Stroke; a journal of cerebral circulation, 1995;26:1781–1786.Google Scholar
  15. 15.
    Handa N, Matsumoto M, Maeda H, Hougaku H, Ogawa S, Fukunaga R, Yoneda S, Kimura K, Kamada T. Ultrasonic evaluation of early carotid atherosclerosis. Stroke; a journal of cerebral circulation, 1990;21:1567–1572.CrossRefGoogle Scholar
  16. 16.
    Wu AH, Gladden JD, Ahmed M, Ahmed A, Filippatos G. Relation of serum uric acid to cardiovascular disease. International journal of cardiology, 2016;213:4–7.CrossRefPubMedGoogle Scholar
  17. 17.
    Zhao G, Huang L, Song M, Song Y. Baseline serum uric acid level as a predictor of cardiovascular disease related mortality and all-cause mortality: a meta-analysis of prospective studies. Atherosclerosis, 2013;231:61–68.CrossRefPubMedGoogle Scholar
  18. 18.
    Fenech G, Rajzbaum G, Mazighi M, Blacher J. Serum uric acid and cardiovascular risk: state of the art and perspectives. Joint, bone, spine: revue du rhumatisme, 2014;81:392–397.CrossRefGoogle Scholar
  19. 19.
    Ishizaka N, Ishizaka Y, Toda E, Nagai R, Yamakado M. Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arteriosclerosis, thrombosis, and vascular biology, 2005;25:1038–1044.CrossRefPubMedGoogle Scholar
  20. 20.
    Kawamoto R, Tomita H, Oka Y, Ohtsuka N. Relationship between serum uric acid concentration, metabolic syndrome and carotid atherosclerosis. Internal medicine, 2006;45:605–614.CrossRefPubMedGoogle Scholar
  21. 21.
    Montalcini T, Gorgone G, Gazzaruso C, Sesti G, Perticone F, Pujia A. Relation between serum uric acid and carotid intima-media thickness in healthy postmenopausal women. Internal and emergency medicine, 2007;2:19–23.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Li Q, Yang Z, Lu B, Wen J, Ye Z, Chen L, He M, Tao X, Zhang W, Huang Y, Zhang Z, Qu S, Hu R. Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetes. Cardiovascular diabetology, 2011;10:72.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Iribarren C, Folsom AR, Eckfeldt JH, McGovern PG, Nieto FJ. Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: the ARIC Study. Atherosclerosis Risk in Communities. Annals of epidemiology, 1996;6:331–340.CrossRefPubMedGoogle Scholar
  24. 24.
    Dobson A. Is raised serum uric acid a cause of cardiovascular disease or death? Lancet, 1999;354:1578.CrossRefPubMedGoogle Scholar
  25. 25.
    Chamorro A, Amaro S, Castellanos M, Segura T, Arenillas J, Marti-Fabregas J, Gallego J, Krupinski J, Gomis M, Canovas D, Carne X, Deulofeu R, Roman LS, Oleaga L, Torres F, Planas AM, Investigators U-I. Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trial. The Lancet Neurology, 2014;13:453–460.CrossRefPubMedGoogle Scholar
  26. 26.
    Amaro S, Llull L, Renu A, Laredo C, Perez B, Vila E, Torres F, Planas AM, Chamorro A. Uric acid improves glucose-driven oxidative stress in human ischemic stroke. Annals of neurology, 2015;77:775–783.CrossRefPubMedGoogle Scholar
  27. 27.
    Nieto FJ, Iribarren C, Gross MD, Comstock GW, Cutler RG. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis, 2000;148:131–139.CrossRefPubMedGoogle Scholar

Copyright information

© Serdi and Springer-Verlag France SAS, part of Springer Nature 2017

Authors and Affiliations

  1. 1.the First Hospital of Jilin UniversityChangchunChina
  2. 2.Department of Neurosurgerythe First Hospital of Jilin UniversityChangchunChina
  3. 3.Cadre WardThe First Hospital of Jilin UniversityChangchunChina
  4. 4.Clinical Trail and Research Center for Stroke, Department of Neurologythe First Hospital of Jilin UniversityChangchunChina

Personalised recommendations